Opendata, web and dolomites

POC products

A novel microfluid-based modular system to address POC challenges within the field of coagulation and hemostasis

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 POC products project word cloud

Explore the words cloud of the POC products project. It provides you a very rough idea of what is the project "POC products" about.

therapies    laboratories    monitoring    coagulation    validation    segments    exists    device    majority    lines    commercialization    ageing    vital    reached    plan    renal    market    health    direct    accelerate    events    follow    solution    network    anticoagulants    ivd    population    size    microsystems    multistep    feasibility    independent    15    create    tests    patented    hemorrhagic    strategy    advertised    care    measured    building    core    possibility    extend    cardiology    kols    critical    run    opportunity    niches    markets    hematology    competitors    outside    modular    poc    reactions    customization    flexibility    distributors    business    improvements    diversify    eliminates    lack    barrier    outcome    clinical    levels    platform    molecular    oral    hospital    corrected    complete    performing    worldwide    centralized    diagnostic    cagr    company    heparin    iline    lowering    weight    patient    monitor    biomarkers    industrialization    monitored    entry    labs    proprietary    emergencies    solutions    hospitals    noacs    sales    opens    prescribed    hemostasis    anticoagulation    microfluidic   

Project "POC products" data sheet

The following table provides information about the project.

Coordinator
ILINE MICROSYSTEMS S.L. 

Organization address
address: CL PASEO MIKELETEGI 69 1
city: DONOSTIA-SAN SEBASTIAN
postcode: 20009
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Project website http://www.ilinemicrosystems.com/nw/
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ILINE MICROSYSTEMS S.L. ES (DONOSTIA-SAN SEBASTIAN) coordinator 50˙000.00

Map

 Project objective

The New Oral Anticoagulants (NOACs) are widely advertised, with CAGR 15%/year, as they lack the necessity for monitoring of the patient. It is now corrected by increased levels of renal failure and hemorrhagic events. The project is focused on the validation and industrialization of new IVD POC device that will provide solutions to monitor low molecular weight heparin and NOACs which are not monitored by any existing POC systems. The proposed solution is improving patient care and management and lowering the increasing cost of centralized patient management related to the ageing of the population. This opens a business opportunity for our company since no POC device exists capable of performing similar diagnostic. Our solution has no direct competitors worldwide. The expected outcome is a complete diagnostic system based on proprietary microfluidic Core Technology patented by iLine Microsystems. This will extend the diagnostic range of the POC anticoagulation therapies that now can only be reached by multistep reactions run in centralized labs and accelerate the development of future tests. The feasibility study will focus on the business plan. Market size and niches can be measured for NOACs and their use in patient’s management. Both new lines of product are aiming at distinct market segments, emergencies, hospital tests or independent laboratories. Commercialization will follow the established strategy of sales via worldwide distributors. This approach eliminates the market entry barrier in hospitals and health care. We are building the clinical network including KOLs in the fields of hematology, cardiology and Critical Care where majority of the NOACs are prescribed and monitoring is vital. The proposed solution, due to its modular design and flexibility, has the unique potential for customization and improvements. The modular platform, create the possibility to diversify the markets and design products based on biomarkers outside of hemostasis and coagulation.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "POC PRODUCTS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "POC PRODUCTS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

PanCareFollowUp (2019)

PanCareFollowUp: Novel, patient-centred survivorship care to improve care quality, effectiveness, cost-effectiveness and accessibility for survivors and caregivers

Read More  

LEGACy (2019)

CeLac and European consortium for a personalized medicine approach to Gastric Cancer

Read More  

HAP2 (2020)

Host-targeted Approaches for the Prevention and the treatment of Hospital-Acquired Pneumonia

Read More